Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the Brazil pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates. - The Brazilian pharmaceuticals market had total revenues of $13.9bn in 2016, representing a compound annual growth rate (CAGR) of 8% between 2012 and 2016. - A large generic shift is expected in the next few years as significant increases in government spending on free and heavily-subsidized drugs will decelerate as the government shifts its focus to cost-containment, coupled with many big patents expiring. - Drug registration with a new electronic system has been introduced under which drugs can be approved within six months, rather than up to two years previously stated.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Brazil - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil - Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Brazil pharmaceuticals market by value in 2016? - What will be the size of the Brazil pharmaceuticals market in 2021? - What factors are affecting the strength of competition in the Brazil pharmaceuticals market? - How has the market performed over the last five years? - Who are the top competitiors in Brazil’s pharmaceuticals market?
Our reports have been used by over 10K customers, including:
Oral Hygiene in Brazil by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2018. This market covers toothpaste, toothbrush and mouthwash and ancillary oral hygiene products. Market size comprises sales through all retail channels including direct to consumer and via dentists....
BRIC Peripheral Vascular Devices Market Outlook to 2025 Summary GlobalData’s new report, BRIC Peripheral Vascular Devices Market Outlook to 2025, provides key market data on the BRIC Peripheral Vascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average...
BRIC Electrophysiology Devices Market Outlook to 2025 Summary GlobalData’s new report, BRIC Electrophysiology Devices Market Outlook to 2025, provides key market data on the BRIC Electrophysiology Devices market. The report provides value, in millions of US dollars, volume (in units) and average...
BRIC Interventional Cardiology Market Outlook to 2025 Summary GlobalData’s new report, BRIC Interventional Cardiology Market Outlook to 2025, provides key market data on the BRIC Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average...
21 pages •
By Euromonitor International
• May 2018
Promotions are often considered to be a default scenario for oral care sales. Leading players continuously invest in offering pack types with interesting discounts to stimulate demand. However, in a more challenging environment, companies are relying further on such strategies to avoid worsening demand. Consumers continued to opt for items...